开云app官网登录入口网页版-官方正版

#胸膜间皮瘤#

10篇内容 | 1473人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2201510, encodeId=c7912201510dd, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a> <a href='/topic/show?id=999f29696b2' target=_blank style='color:#2F92EE;'>#全身治疗#</a>, objectTitle=惊讶？肿瘤延迟治疗、不做全身治疗的生存期差不多延长了1倍！, objectType=article, longId=824048, objectId=beaa824048f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=beaa824048f9, replyNumber=0, likeNumber=53, createdTime=2024-05-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=beaa824048f9, moduleTitle=惊讶？肿瘤延迟治疗、不做全身治疗的生存期差不多延长了1倍！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=beaa824048f9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183340, encodeId=3b292183340e4, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a> <a href='/topic/show?id=af7b4e36370' target=_blank style='color:#2F92EE;'>#尼拉帕利#</a> <a href='/topic/show?id=4e6c11042e26' target=_blank style='color:#2F92EE;'>#多塔利单抗#</a> <a href='/topic/show?id=f9e5110428d7' target=_blank style='color:#2F92EE;'>#HRR基因突变#</a>, objectTitle=尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果, objectType=article, longId=810460, objectId=52a681046061, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=52a681046061, replyNumber=0, likeNumber=75, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=52a681046061, moduleTitle=尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=52a681046061)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2172339, encodeId=c60721e2339f3, content=<a href='/topic/show?id=4bbf8228ef5' target=_blank style='color:#2F92EE;'>#肺结节#</a> <a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a> <a href='/topic/show?id=cb6d858197f' target=_blank style='color:#2F92EE;'>#膈肌#</a>, objectTitle=罕见病例：稳定了4年的胸腔内病变，缘何在半年月内突然爆发进展？——从医27年之所未见！, objectType=article, longId=803025, objectId=284d80302542, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867316202_4754896.png, objectUrl=/article/show_article.do?id=284d80302542, replyNumber=0, likeNumber=77, createdTime=2023-12-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=284d80302542, moduleTitle=罕见病例：稳定了4年的胸腔内病变，缘何在半年月内突然爆发进展？——从医27年之所未见！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=284d80302542)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241582, encodeId=8ee4124158229, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a><a href='/topic/show?id=b5f71041887c' target=_blank style='color:#2F92EE;'>#ADC类药物#</a><a href='/topic/show?id=22099696e4f' target=_blank style='color:#2F92EE;'>#长春瑞滨#</a>, objectTitle=Lancet Oncol：采用ADC药物Anetumab ravtansine治疗恶性胸膜间皮瘤的疗效和安全性, objectType=article, longId=723522, objectId=d134e23522a2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220404/1649084635107_2110107.JPG, objectUrl=/article/show_article.do?id=d134e23522a2, replyNumber=0, likeNumber=109, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d134e23522a2, moduleTitle=Lancet Oncol：采用ADC药物Anetumab ravtansine治疗恶性胸膜间皮瘤的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d134e23522a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241583, encodeId=ca6812415833d, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤, objectType=article, longId=727301, objectId=6669e2730156, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220518/1652879872967_2110107.JPG, objectUrl=/article/show_article.do?id=6669e2730156, replyNumber=0, likeNumber=75, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6669e2730156, moduleTitle=Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6669e2730156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241584, encodeId=401d124158482, content=<a href='/topic/show?id=ce279885039' target=_blank style='color:#2F92EE;'>#雷莫芦单抗#</a>+<a href='/topic/show?id=10dc3890e66' target=_blank style='color:#2F92EE;'>#吉西他滨#</a>作为二线疗法可显著延长恶性<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>患者的生存期, objectTitle=Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！, objectType=article, longId=216812, objectId=832d216812a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202197/1631015730035_2110107.JPG, objectUrl=/article/show_article.do?id=832d216812a4, replyNumber=0, likeNumber=110, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=832d216812a4, moduleTitle=Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=832d216812a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201342, encodeId=97241201342f8, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=Lancet Oncol：以放疗后继胸膜外全肺切除术治疗恶性胸膜间皮瘤, objectType=article, longId=205843, objectId=21372058433a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/118.jpg, objectUrl=/article/show_article.do?id=21372058433a, replyNumber=0, likeNumber=90, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21372058433a, moduleTitle=Lancet Oncol：以放疗后继胸膜外全肺切除术治疗恶性胸膜间皮瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=21372058433a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201341, encodeId=a5b112013410b, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=中国恶性胸膜间皮瘤临床诊疗指南（2021版），5分钟get要点！, objectType=article, longId=212767, objectId=e93d212e67f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021615/1623749897279_92910.png, objectUrl=/article/show_article.do?id=e93d212e67f4, replyNumber=0, likeNumber=100, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93d212e67f4, moduleTitle=中国恶性胸膜间皮瘤临床诊疗指南（2021版），5分钟get要点！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e93d212e67f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201340, encodeId=bd70120134062, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=Thorax：恶性胸膜和腹膜间皮瘤的发病率、治疗和生存率, objectType=article, longId=295589, objectId=89fd2955899b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2022213/1644747308377_1739456.jpg, objectUrl=/article/show_article.do?id=89fd2955899b, replyNumber=0, likeNumber=114, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89fd2955899b, moduleTitle=Thorax：恶性胸膜和腹膜间皮瘤的发病率、治疗和生存率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=89fd2955899b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201339, encodeId=05a71201339b3, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=2021 ESMO临床实践指南：恶性胸膜间皮瘤的诊断，治疗和随访, objectType=guider, longId=15487, objectId=dcc901c00228a824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=dcc901c00228a824, replyNumber=0, likeNumber=111, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcc901c00228a824, moduleTitle=2021 ESMO临床实践指南：恶性胸膜间皮瘤的诊断，治疗和随访, moduleType=guider, hrefUrl=//m.sandwebs.com/guideline/show_article.do?id=dcc901c00228a824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201338, encodeId=8b8812013386e, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=中国恶性胸膜间皮瘤临床诊疗指南(2021版), objectType=guider, longId=13732, objectId=383f21c0021093d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=383f21c0021093d5, replyNumber=0, likeNumber=103, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=383f21c0021093d5, moduleTitle=中国恶性胸膜间皮瘤临床诊疗指南(2021版), moduleType=guider, hrefUrl=//m.sandwebs.com/guideline/show_article.do?id=383f21c0021093d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201337, encodeId=a758120133e44, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>与<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#肿瘤微环境#</a>, objectTitle=Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境, objectType=article, longId=208935, objectId=ef2720893512, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021324/1616516201356_2467676.PNG, objectUrl=/article/show_article.do?id=ef2720893512, replyNumber=0, likeNumber=105, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2720893512, moduleTitle=Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ef2720893512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=885743, encodeId=2a47885e4308, content=<a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a>, objectTitle=从入选主席研讨会到燃爆全球，听WCLC大会主席吴一龙教授谈胸膜间皮瘤治疗新突破, objectType=article, longId=200734, objectId=d5a1200e34de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/504.jpg, objectUrl=/article/show_article.do?id=d5a1200e34de, replyNumber=0, likeNumber=170, createdTime=2020-09-16, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5a1200e34de, moduleTitle=从入选主席研讨会到燃爆全球，听WCLC大会主席吴一龙教授谈胸膜间皮瘤治疗新突破, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d5a1200e34de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

胸膜间皮瘤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#胸膜间皮瘤# #全身治疗#

惊讶？肿瘤延迟治疗、不做全身治疗的生存期差不多延长了1倍！

2024-05-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#NSCLC# #胸膜间皮瘤# #尼拉帕利# #多塔利单抗# #HRR基因突变#

尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果

2024-01-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#肺结节# #胸膜间皮瘤# #膈肌#

罕见病例：稳定了4年的胸腔内病变，缘何在半年月内突然爆发进展？——从医27年之所未见！

2023-12-01发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#胸膜间皮瘤##ADC类药物##长春瑞滨#

Lancet Oncol：采用ADC药物Anetumab ravtansine治疗恶性胸膜间皮瘤的疗效和安全性

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#雷莫芦单抗#+#吉西他滨#作为二线疗法可显著延长恶性#胸膜间皮瘤#患者的生存期

Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！

2022-08-28

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

Lancet Oncol：以放疗后继胸膜外全肺切除术治疗恶性胸膜间皮瘤

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

中国恶性胸膜间皮瘤临床诊疗指南（2021版），5分钟get要点！

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

Thorax：恶性胸膜和腹膜间皮瘤的发病率、治疗和生存率

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

2021 ESMO临床实践指南：恶性胸膜间皮瘤的诊断，治疗和随访

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

中国恶性胸膜间皮瘤临床诊疗指南(2021版)

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#胸膜间皮瘤#与#肿瘤微环境#

Nat Commun：恶性胸膜间皮瘤的克隆结构可作为预后指标并影响肿瘤微环境

2022-03-10

lovetcm (审核中...)

前往app查看评论内容

#胸膜间皮瘤#

从入选主席研讨会到燃爆全球，听WCLC大会主席吴一龙教授谈胸膜间皮瘤治疗新突破

2020-09-16

科室
- - 订阅+
  - 更多科室
工具
服务